Abstract:Purpose/Objective(s)Neo-adjuvant hormonal therapy (NHT) has nowadays been commonly administered to prostate cancer patients before receiving radiation therapy. Several studies have indicated that length and volume of the seminal vesicles (SVs) would reduce after receiving NHT. However, so far there is no detailed study concerning this issue. In this study, we performed a detailed analysis of the MR images both before and after NHT of the same group of patients, in order to determine the morphological alteration of the SVs and the MR detectable invasions within, and to see whether the SV segment included within the CTV could be reduced in intermediate- and high-risk patients.Materials/MethodsMR images (including a 3-dimension sequence) both prior and after NHT of 31 patients with localized or locally advanced prostate cancer were retrospectively reviewed. Image process as well as analysis were accomplished by the collaboration of one radiologist and one radiation oncologist. Long axis of the SV was located on a reconstructed oblique coronary plane containing both the starting and ending point of the SV. It was determined by drawing a curve connecting both endings along the center line of the SV contour in this plane. Volume of the SV and the MR detectable invasion was defined as the product of the total area in all slices and the slice thickness.ResultsVolume of SV showed an evident reduction after a median of 5 months’ NHT (median: 39.9%, range: 9.4%-66.2%). The median shortening rate of the SV length was 12.1% (range: 4.0%-28.0%). Factors associated with a higher shortening rate include clinical T3b-T4 stage, locally advanced tumor, and MRI detectable invasion. For SVs with and without MR detectable invasions, the length shortening was 16.7±4.8% and 11.1±4.4% (P<0.001); for the 12 invaded SVs and the invasions within, the volume reduction was 41.0±16.0% and 66.3±14.4% (P<0.001), both indicating that reduction rate of the invaded portion was higher or at least not lower than that of the normal portion of the SV.ConclusionsAfter a certain period of NHT, both the SVs and tumor invasions within could reduce a lot. We also found that the invaded portion reduced more than the normal portion of the SV, which indicates that the microscopic invasion would reduce more than normal SV tissue and the SV segment included within the CTV could be reduced in intermediate- and high-risk patients. Purpose/Objective(s)Neo-adjuvant hormonal therapy (NHT) has nowadays been commonly administered to prostate cancer patients before receiving radiation therapy. Several studies have indicated that length and volume of the seminal vesicles (SVs) would reduce after receiving NHT. However, so far there is no detailed study concerning this issue. In this study, we performed a detailed analysis of the MR images both before and after NHT of the same group of patients, in order to determine the morphological alteration of the SVs and the MR detectable invasions within, and to see whether the SV segment included within the CTV could be reduced in intermediate- and high-risk patients. Neo-adjuvant hormonal therapy (NHT) has nowadays been commonly administered to prostate cancer patients before receiving radiation therapy. Several studies have indicated that length and volume of the seminal vesicles (SVs) would reduce after receiving NHT. However, so far there is no detailed study concerning this issue. In this study, we performed a detailed analysis of the MR images both before and after NHT of the same group of patients, in order to determine the morphological alteration of the SVs and the MR detectable invasions within, and to see whether the SV segment included within the CTV could be reduced in intermediate- and high-risk patients. Materials/MethodsMR images (including a 3-dimension sequence) both prior and after NHT of 31 patients with localized or locally advanced prostate cancer were retrospectively reviewed. Image process as well as analysis were accomplished by the collaboration of one radiologist and one radiation oncologist. Long axis of the SV was located on a reconstructed oblique coronary plane containing both the starting and ending point of the SV. It was determined by drawing a curve connecting both endings along the center line of the SV contour in this plane. Volume of the SV and the MR detectable invasion was defined as the product of the total area in all slices and the slice thickness. MR images (including a 3-dimension sequence) both prior and after NHT of 31 patients with localized or locally advanced prostate cancer were retrospectively reviewed. Image process as well as analysis were accomplished by the collaboration of one radiologist and one radiation oncologist. Long axis of the SV was located on a reconstructed oblique coronary plane containing both the starting and ending point of the SV. It was determined by drawing a curve connecting both endings along the center line of the SV contour in this plane. Volume of the SV and the MR detectable invasion was defined as the product of the total area in all slices and the slice thickness. ResultsVolume of SV showed an evident reduction after a median of 5 months’ NHT (median: 39.9%, range: 9.4%-66.2%). The median shortening rate of the SV length was 12.1% (range: 4.0%-28.0%). Factors associated with a higher shortening rate include clinical T3b-T4 stage, locally advanced tumor, and MRI detectable invasion. For SVs with and without MR detectable invasions, the length shortening was 16.7±4.8% and 11.1±4.4% (P<0.001); for the 12 invaded SVs and the invasions within, the volume reduction was 41.0±16.0% and 66.3±14.4% (P<0.001), both indicating that reduction rate of the invaded portion was higher or at least not lower than that of the normal portion of the SV. Volume of SV showed an evident reduction after a median of 5 months’ NHT (median: 39.9%, range: 9.4%-66.2%). The median shortening rate of the SV length was 12.1% (range: 4.0%-28.0%). Factors associated with a higher shortening rate include clinical T3b-T4 stage, locally advanced tumor, and MRI detectable invasion. For SVs with and without MR detectable invasions, the length shortening was 16.7±4.8% and 11.1±4.4% (P<0.001); for the 12 invaded SVs and the invasions within, the volume reduction was 41.0±16.0% and 66.3±14.4% (P<0.001), both indicating that reduction rate of the invaded portion was higher or at least not lower than that of the normal portion of the SV. ConclusionsAfter a certain period of NHT, both the SVs and tumor invasions within could reduce a lot. We also found that the invaded portion reduced more than the normal portion of the SV, which indicates that the microscopic invasion would reduce more than normal SV tissue and the SV segment included within the CTV could be reduced in intermediate- and high-risk patients. After a certain period of NHT, both the SVs and tumor invasions within could reduce a lot. We also found that the invaded portion reduced more than the normal portion of the SV, which indicates that the microscopic invasion would reduce more than normal SV tissue and the SV segment included within the CTV could be reduced in intermediate- and high-risk patients.

The Optimal Clinical Target Volume for the Seminal Vesicle in Localized Prostate Cancer Radiotherapy

Optimal contouring of seminal vesicle for definitive radiotherapy of localized prostate cancer: comparison between EORTC prostate cancer radiotherapy guideline, RTOG0815 protocol and actual anatomy

Postoperative Radiotherapy For Glioma: Improved Delineation Of The Clinical Target Volume Using The Geodesic Distance Calculation

Neoadjuvent Androgen Deprivation for Seminal Vesicle Reduction:The Optimal Portion of Seminal Vesicle Included in the High-Dose CTV in Localized Prostate Cancer Radiotherapy

Reduction of Seminal Vesicle after Androgen Deprivation Therapy:Effects of Neo-Adjuvant or Monal Therapy to the Target Volume of Seminal Vesicles in Prostate Cancer Radiotherapy

Dosimetric Analysis of Radiation Treatment Plans Based on a Deep Learning Auto Contouring Model for Patients with Localized Prostate Cancer

Impact Of Interfractional Motion On Hypofractionated Pencil Beam Scanning Proton Therapy And Vmat Delivery For Prostate Cancer

Neoadjuvant Hormonal Therapy On Seminal Vesicles Reduction: Optimal Clinical Target Volume For The Seminal Vesicles In Localized Prostate Cancer Radiation Therapy

Evaluation Of The Dosimetric Impact Of Interfractional Anatomical Variations On Prostate Proton Therapy Using Daily In-Room Ct Images

Target Volume Optimization for Localized Prostate Cancer

Ultrahypofractionated Radiation Therapy for Prostate Cancer Including Seminal Vesicles in the Target Volume: A Treatment-planning Study Based on the HYPO-RT-PC Fractionation Schedule

Is it necessary to prescribe the same dose to subclinical lesions as gross tumor volume in non-small-cell lung cancer? —a failure pattern analysis

A Dosimetric Comparison Between Conventional Fractionated and Hypofractionated Image-guided Radiation Therapies for Localized Prostate Cancer

Image Registration and Target Volume Margins in Cone-Beam Computed Tomography-Guided Intensity-Modulated Radiotherapy for Prostate Cancer

The Target Design and the Protective Effect of the 3D Conformal Radiotherapy in Localized Prostate Cancer

[Factors Influencing Clinical Target Volume Delineation of Intact Breast in Intensity-Modulated Radiotherapy for Breast Cancer].

Pancreatic Cancer Adjuvant Radiotherapy Target Volume Design: Based on the Postoperative Local Recurrence Spatial Location

Neurovascular Bundle-Sparing Radiotherapy for Prostate Cancer Using MRI-CT Registration: A Dosimetric Feasibility Study.

Biologic Target Volume Delineation and the Application of Three-Dimensional Ultrasound Image System in Hypofractional Radiotherapy for Prostate Cancer.

A novel approach for evaluation of prostate deformation and associated dosimetric implications in IGRT of the prostate.

A Comparison Study Between Gross Tumor Volumes Defined by Preoperative Magnetic Resonance Imaging, Postoperative Specimens, and Tumor Bed for Radiation Therapy after Breast-Conserving Surgery